Sorrento Therapeutics (SRNE) stock Forecast for 2021 – 2025

Sorrento Therapeutics (SRNE) stock Forecast for 2022 – 2026

Last update: November 26, 2022 (17:55)

Sector: Healthcare

The share price of Sorrento Therapeutics, Inc. (SRNE) now

What analysts predict: $12

52-week high/low: $6.53 / $1.15

50/200 Day Moving Average: $1.599 / $2.037

This figure corresponds to the average price over the previous 50/200 days. For Sorrento Therapeutics stocks, the 50-day moving average is the resistance level today.

For Sorrento Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Sorrento Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Sorrento Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Sorrento Therapeutics share be worth in 2022 - 2026?

When should I take profit in Sorrento Therapeutics stock? When should I record a loss on Sorrento Therapeutics stock? What are analysts' forecasts for Sorrento Therapeutics stock? What is the future of Sorrento Therapeutics stock? We forecast Sorrento Therapeutics stock performance using neural networks based on historical data on Sorrento Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Sorrento Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Sorrento Therapeutics shares. This happens once a day.




Historical and forecast chart of Sorrento Therapeutics stock

The chart below shows the historical price of Sorrento Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Sorrento Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Sorrento Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 28 1.34 1.28 1.39 8.33
Nov 29 1.33 1.27 1.36 6.75
Nov 30 1.33 1.31 1.36 4.20
Dec 01 1.29 1.24 1.31 5.55
Dec 02 1.33 1.29 1.36 5.31
Dec 03 1.40 1.37 1.46 6.43
Dec 04 1.38 1.34 1.43 6.78
Dec 05 1.41 1.38 1.43 3.55
Dec 06 1.47 1.43 1.52 6.21
Dec 07 1.47 1.45 1.51 4.21
Dec 08 1.41 1.38 1.46 5.08
Dec 09 1.46 1.40 1.50 6.61
Dec 10 1.42 1.37 1.44 4.84
Dec 11 1.45 1.39 1.48 5.88
Dec 12 1.52 1.48 1.54 4.31
Dec 13 1.57 1.53 1.59 3.62
Dec 14 1.53 1.49 1.59 6.99
Dec 15 1.57 1.52 1.62 6.36
Dec 16 1.50 1.46 1.55 6.31
Dec 17 1.44 1.39 1.47 6.03
Dec 18 1.40 1.37 1.44 5.53
Dec 19 1.43 1.41 1.48 5.37
Dec 20 1.41 1.38 1.43 3.93
Dec 21 1.42 1.37 1.46 6.52
Dec 22 1.45 1.38 1.48 7.09
Dec 23 1.46 1.40 1.50 6.93
Dec 24 1.45 1.40 1.48 5.54
Dec 25 1.49 1.43 1.54 7.81
Dec 26 1.49 1.47 1.55 5.36
Dec 27 1.47 1.44 1.54 6.62

Sorrento Therapeutics Daily Price Targets


Sorrento Therapeutics Stock Forecast 11-28-2022.

Forecast target price for 11-28-2022: $1.34.
Negative dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 7.685%.
Pessimistic target level: 1.28
Optimistic target level: 1.39

Sorrento Therapeutics Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $1.33.
Negative dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 6.320%.
Pessimistic target level: 1.27
Optimistic target level: 1.36

Sorrento Therapeutics Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $1.33.
Positive dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 4.031%.
Pessimistic target level: 1.31
Optimistic target level: 1.36

Sorrento Therapeutics Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $1.29.
Negative dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 5.260%.
Pessimistic target level: 1.24
Optimistic target level: 1.31

Sorrento Therapeutics Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $1.33.
Positive dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 5.045%.
Pessimistic target level: 1.29
Optimistic target level: 1.36

Sorrento Therapeutics Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $1.40.
Positive dynamics for Sorrento Therapeutics shares will prevail with possible volatility of 6.046%.
Pessimistic target level: 1.37
Optimistic target level: 1.46

SRNE (SRNE) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 1.39 1.24 1.46 15.57

Sorrento Therapeutics forecast for this year


Sorrento Therapeutics Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $1.39468. Pessimistic: $1.24. Optimistic: $1.46



Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 1.43 1.31 1.64 19.66
Feb 1.31 1.12 1.46 23.06
Mar 1.10 1.05 1.24 15.17
Apr 1.06 0.99 1.11 10.68
May 1.20 1.05 1.38 23.79
Jun 1.35 1.20 1.45 17.01
Jul 1.26 1.12 1.43 21.46
Aug 1.16 1.01 1.30 22.42
Sep 1.15 1.09 1.28 14.69
Oct 1.06 0.99 1.21 18.34
Nov 1.04 0.90 1.17 22.75
Dec 1.09 1.03 1.18 12.34

Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 1.25 1.15 1.42 19.52
Feb 1.15 1.04 1.29 19.62
Mar 1.22 1.11 1.30 14.96
Apr 1.15 1.06 1.26 15.64
May 1.34 1.22 1.47 17.49
Jun 1.39 1.24 1.58 21.13
Jul 1.38 1.29 1.44 10.32
Aug 1.24 1.18 1.41 16.66
Sep 1.23 1.13 1.28 11.90
Oct 1.15 1.09 1.23 10.75
Nov 1.28 1.12 1.37 18.72
Dec 1.34 1.17 1.43 18.11

Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 1.33 1.19 1.48 19.48
Feb 1.28 1.21 1.41 14.18
Mar 1.08 0.97 1.23 20.89
Apr 0.92 0.84 0.96 12.83
May 0.99 0.93 1.10 15.03
Jun 0.97 0.92 1.10 16.19
Jul 0.96 0.82 1.10 25.19
Aug 1.03 0.94 1.13 16.63
Sep 0.99 0.88 1.07 17.39
Oct 0.94 0.87 1.01 14.48
Nov 0.91 0.82 1.03 20.76
Dec 0.85 0.76 0.98 22.21

Sorrento Therapeutics (SRNE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.83 0.78 0.92 15.77
Feb 0.89 0.81 0.99 18.08
Mar 0.81 0.73 0.84 13.55
Apr 0.83 0.73 0.91 19.54
May 0.87 0.77 1.00 22.63
Jun 0.80 0.73 0.84 13.89
Jul 0.76 0.72 0.87 17.32
Aug 0.84 0.72 0.97 25.61
Sep 0.96 0.83 1.06 21.60
Oct 1.07 1.03 1.15 10.49
Nov 1.26 1.16 1.32 12.17
Dec 1.43 1.28 1.50 14.85

Sorrento Therapeutics information and performance

Sorrento Therapeutics, Inc., a clinical stage Biopharma company, develops treatments for cancer, autoimmune, inflammatory and neurodegenerative diseases. She operates in two segments – Sorrento Therapeutics and Scilex. The company provides cancer therapists through the use of a proprietary r-monoclonal antibody antibody library and targeted delivery conditions that include chimeric antigen receptor T-cell therapy (car-T), dimeric antigen receptor T-cell therapy, and antibody-drug conjugates as well as bispecific antibody approaches. It also offers Sofusa, a drug delivery technology that delivers biological substances directly to the lymphatic system. In addition, the company’s clinical programs include anti-CD38 CAR-T therapy for the treatment of multiple myeloma as well as amyloidosis and graft versus host diseases. In addition, he is developing resiniferatoxin, a neopioid-based TRPV1 agonist neurotoxin for the treatment of advanced cancer and osteoarthritis of knee pain; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. In addition, the company is developing SEMDEXA, an injectable viscous gel formulation that is a Phase III trial for the treatment of sciatica, a pathology of low back pain; and SP-103, an investigational non-aqueous lidocaine topical system in clinical development for chronic low back pain. She has various collaborations with SmartPharm Therapeutics Inc. to develop a gene-encoded vaccine antibody to protect against COVID-19; Celularity, Inc. to initiate a Phase I / II clinical trial with up to 86 COVID-19 patients; and the Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection, and a Research Trials Agreement with the University of Texas Medical Branch at Galveston for preclinical testing of Sorrento’s COVID-19 therapeutic product candidates. The company was founded in 2006 and is based in San Diego, California.

Sorrento Therapeutics Address

4955 DIRECTORS PLACE, SAN DIEGO, CA, US

Market Capitalization: 674 788 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -390 896 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.07

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.527

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.443
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 1.178

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 12.02

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.429

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 471880000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.